HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Miyoshi myopathy

Also Known As:
Miyoshi distal myopathy; Muscular dystrophy, distal, late onset, autosomal recessive
Networked: 127 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Nishino, Ichizo: 6 articles (09/2009 - 06/2003)
2. Bushby, Kate: 5 articles (02/2011 - 03/2007)
3. Bushby, K: 5 articles (04/2008 - 09/2000)
4. Brown, Robert H: 4 articles (09/2014 - 09/2004)
5. Takahashi, Toshiaki: 4 articles (04/2013 - 05/2004)
6. Aoki, Masashi: 4 articles (04/2013 - 05/2004)
7. Straub, Volker: 4 articles (09/2010 - 03/2007)
8. Anderson, L V: 4 articles (04/2008 - 04/2000)
9. Krahn, Martin: 3 articles (12/2015 - 07/2008)
10. Sinnreich, Michael: 3 articles (01/2015 - 01/2010)

Related Diseases

1. Distal Myopathies (Distal Muscular Dystrophy)
2. Muscular Diseases (Myopathy)
3. Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
05/01/2004 - "With the diagnostic specificity conferred by the absence of expression by a specific protein or a mutation of a specific gene, we have learned that similar clinical phenotype may occur in different diseases, such as Duchenne muscular dystrophy and gamma-sarcoglycanopathy, but also that mutations in the same gene may cause different clinical phenotypes, as occurs in Miyoshi distal myopathy and limb girdle muscular dystrophy 2B, both caused by mutations in the dysferlin gene. "
10/23/2007 - "We describe 185 miRNAs that are up- or down-regulated in 10 major muscular disorders in humans [Duchenne muscular dystrophy (DMD), Becker muscular dystrophy, facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophies types 2A and 2B, Miyoshi myopathy, nemaline myopathy, polymyositis, dermatomyositis, and inclusion body myositis]. "
05/01/2005 - "In this study, we investigated the proteolysis of beta-dystroglycan in the biopsied skeletal muscles of various human muscular diseases, including sarcoglycanopathy, Duchenne muscular dystrophy (DMD), Becker muscular dystrophy, Fukuyama congenital muscular dystrophy, Miyoshi myopathy, LGMD2A, facioscapulohumeral muscular dystrophy, myotonic dystrophy and dermatomyositis/polymyositis. "
01/01/2013 - "Spinal muscular atrophy (SMA), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy (DMD), Fukuyama congenital muscular dystrophy (FCMD), dysferlinopathy (including limb-girdle muscular dystrophy 2B; LGMD2B, Miyoshi myopathy; MM, and distal myopathy with anterior tibial onset; DMAT), and myotonic dystrophy (DM) are all reported to be promising targets for antisense therapy. "
4. Walker-Warburg Syndrome
5. Sarcoglycanopathies

Related Drugs and Biologics

1. Dystroglycans (Dystroglycan)
2. type 2B Limb-girdle muscular dystrophy
3. Dysferlinopathy
4. Rigid spine syndrome
5. Staphylococcal Protein A (A, Protein)
6. Membrane Proteins (Integral Membrane Proteins)
7. Creatine Kinase (Creatine Phosphokinase)
8. MicroRNAs (MicroRNA)
9. Myosins (Myosin)
10. Dystrophia myotonica 1